Retatrutide is an investigational peptide that activates GLP-1, GIP, and glucagon receptors simultaneously, making it an area of ongoing metabolic research
Your first point of contact for any concerns about your trial medication should be your trial team , who are best placed to assess whether symptoms may be related to the investigational medicine and to advise on next steps
Once your diarrhea resolves, you can slowly add more high-fiber foods back into your diet
The 1996 raspberry outbreak was so large that it fundamentally changed how public health agencies investigate produce-associated outbreaks
No evidence shows that semaglutide causes *new* weight gain beyond the starting pointregain occurs because the appetite-suppressing effect ends
Thereby improving the skins ability to resist oxidation, giving the skin a luster and achieving a whitening effect